Current practices for pediatric phototherapy: Findings from a cross-sectional study

Riley K Spencer1,2, Erin Bartholomew1, Jessica Padniewski3

  • 1Department of Dermatology, University of California San Francisco, San Francisco, California, USA.

Pediatric Dermatology
|November 29, 2023
PubMed

Insights

Pediatric phototherapy lacks specific guidelines, leading to varied practices. This study surveyed 39 US sites, finding common use of informed consent, no minimum age, Fitzpatrick skin typing for dosing, and parental accompaniment in lightboxes.

Area of Science:

  • Dermatology
  • Pediatric Phototherapy
  • Clinical Practice

Background:

  • Phototherapy is a common treatment for pediatric inflammatory skin conditions.
  • Lack of specific guidelines for pediatric phototherapy results in inconsistent treatment protocols.
  • Variability in pediatric phototherapy implementation necessitates an understanding of current practices.

Purpose of the Study:

  • To investigate current implementation practices of phototherapy in pediatric patients across the United States.
  • To identify common themes and variations in pediatric phototherapy procedures.
  • To provide insights for developing standardized pediatric phototherapy guidelines.

Main Methods:

  • A cross-sectional, survey-based study was conducted.
  • Data were collected from 39 clinical sites across 19 states in the US.
  • Sites were identified through the National Psoriasis Foundation (NPF) Health Care Provider Directory.

Main Results:

  • 100% of responding sites used Fitzpatrick skin type for phototherapy dosing.
  • 91.8% of sites had no minimum age requirement for pediatric patients.
  • 86.4% required informed consent, and 65% allowed parents in the lightbox with children.

Conclusions:

  • Current pediatric phototherapy practices show considerable variability, particularly regarding age and parental accompaniment.
  • The universal use of Fitzpatrick skin typing suggests a potential basis for standardized dosing protocols.
  • Further research is needed to establish evidence-based guidelines for safe and effective pediatric phototherapy.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...